Neovascularization in Tissue Engineering

A prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release o...

Full description

Bibliographic Details
Main Authors: Jennifer C.-Y. Chung, Dominique Shum-Tim
Format: Article
Language:English
Published: MDPI AG 2012-12-01
Series:Cells
Subjects:
Online Access:http://www.mdpi.com/2073-4409/1/4/1246
id doaj-46f062ebb33c486ba6cd65339a118dd3
record_format Article
spelling doaj-46f062ebb33c486ba6cd65339a118dd32020-11-24T23:59:55ZengMDPI AGCells2073-44092012-12-01141246126010.3390/cells1041246Neovascularization in Tissue EngineeringJennifer C.-Y. ChungDominique Shum-TimA prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release of these angiogenic proteins. Cell-based therapy using endothelial cells and their precursors presents an alternative approach to tackling this challenge. These studies have occurred on a background of advancements in scaffold design and assays for assessing neovascularization. Finally, several studies have already attempted to translate research in neovascularization to clinical use in the blossoming field of therapeutic angiogenesis.http://www.mdpi.com/2073-4409/1/4/1246neovascularizationangiogenesistherapeutic angiogenesisendothelial progenitor cells
collection DOAJ
language English
format Article
sources DOAJ
author Jennifer C.-Y. Chung
Dominique Shum-Tim
spellingShingle Jennifer C.-Y. Chung
Dominique Shum-Tim
Neovascularization in Tissue Engineering
Cells
neovascularization
angiogenesis
therapeutic angiogenesis
endothelial progenitor cells
author_facet Jennifer C.-Y. Chung
Dominique Shum-Tim
author_sort Jennifer C.-Y. Chung
title Neovascularization in Tissue Engineering
title_short Neovascularization in Tissue Engineering
title_full Neovascularization in Tissue Engineering
title_fullStr Neovascularization in Tissue Engineering
title_full_unstemmed Neovascularization in Tissue Engineering
title_sort neovascularization in tissue engineering
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2012-12-01
description A prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release of these angiogenic proteins. Cell-based therapy using endothelial cells and their precursors presents an alternative approach to tackling this challenge. These studies have occurred on a background of advancements in scaffold design and assays for assessing neovascularization. Finally, several studies have already attempted to translate research in neovascularization to clinical use in the blossoming field of therapeutic angiogenesis.
topic neovascularization
angiogenesis
therapeutic angiogenesis
endothelial progenitor cells
url http://www.mdpi.com/2073-4409/1/4/1246
work_keys_str_mv AT jennifercychung neovascularizationintissueengineering
AT dominiqueshumtim neovascularizationintissueengineering
_version_ 1725445627538571264